H. J. Schünemann, S. R. Hill, M. Kakad et al.: WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. In: Lancet Infect Dis. 7. Jahrgang, Nr.1, Januar 2007, S.21–31, doi:10.1016/S1473-3099(06)70684-3, PMID 17182341.
Tom Jefferson, Mark A Jones, Peter Doshi et al.: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. In: British Medical Journal. 2014, Online-Vorabveröffentlichung vom 10. April 2014, doi:10.1002/14651858.CD008965.pub4.
T. Jefferson, V. Demicheli, D. Rivetti, M. Jones, C. Di Pietrantonj, A. Rivetti: Antivirals for influenza in healthy adults: systematic review. In: Lancet. Band 367, Nummer 9507, Januar 2006, S. 303–313, doi:10.1016/S0140-6736(06)67970-1, PMID 16443037 (Review).
Toshihiro Tanaka et al.: Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. In: Canadian Medical Association Journal. 2009, Band 181, Nr. 1–2, S. 55–58, doi:10.1503/cmaj.090866.
T Mita, N Fukuda, FX Roca, M Kanai, M Shibasaki: Second generation catalytic asymmetric synthesis of Tamiflu: allylic substitution route. In: Org. Lett. 9. Jahrgang, Nr.2, Januar 2007, S.259–262, doi:10.1021/ol062663c, PMID 17217279.
Satoh N, Akiba T, Yokoshima S, Fukuyama T: A practical synthesis of (−)-oseltamivir. In: Angew. Chem. Int. Ed. Engl. 46. Jahrgang, Nr.30, 2007, S.5734–5736, doi:10.1002/anie.200701754, PMID 17594704 (pitt.edu [PDF]).
BM Trost, T Zhang: A concise synthesis of (−)-oseltamivir. In: Angew. Chem. Int. Ed. Engl. 47. Jahrgang, Nr.20, 2008, S.3759–3761, doi:10.1002/anie.200800282, PMID 18399551.
Ying-Yeung Yeung, Sungwoo Hong, E. J. Corey: A Short Enantioselective Pathway for the Synthesis of the Anti-Influenza Neuramidase Inhibitor Oseltamivir from 1,3-Butadiene and Acrylic Acid. In: J. Am. Chem. Soc., 2006, 128(19), S. 6310–6311; (Communication) doi:10.1021/ja0616433.
N. J. Dharan, L. V. Gubareva, J. J. Meyer et al.: Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States. In: JAMA. 2. März 2009, Band 301, Nr. 10, doi:10.1001/jama.2009.294.
A. Wallenstein et al.: Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England. In: Eurosurveillance. Band 14, Nr. 30, 2009, Volltext.
handelsblatt.com
handelsblatt.com und diverse Agenturmeldungen vom 22. März 2007.
H. J. Schünemann, S. R. Hill, M. Kakad et al.: WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. In: Lancet Infect Dis. 7. Jahrgang, Nr.1, Januar 2007, S.21–31, doi:10.1016/S1473-3099(06)70684-3, PMID 17182341.
T. Jefferson, V. Demicheli, D. Rivetti, M. Jones, C. Di Pietrantonj, A. Rivetti: Antivirals for influenza in healthy adults: systematic review. In: Lancet. Band 367, Nummer 9507, Januar 2006, S. 303–313, doi:10.1016/S0140-6736(06)67970-1, PMID 16443037 (Review).
T Mita, N Fukuda, FX Roca, M Kanai, M Shibasaki: Second generation catalytic asymmetric synthesis of Tamiflu: allylic substitution route. In: Org. Lett. 9. Jahrgang, Nr.2, Januar 2007, S.259–262, doi:10.1021/ol062663c, PMID 17217279.
Satoh N, Akiba T, Yokoshima S, Fukuyama T: A practical synthesis of (−)-oseltamivir. In: Angew. Chem. Int. Ed. Engl. 46. Jahrgang, Nr.30, 2007, S.5734–5736, doi:10.1002/anie.200701754, PMID 17594704 (pitt.edu [PDF]).
BM Trost, T Zhang: A concise synthesis of (−)-oseltamivir. In: Angew. Chem. Int. Ed. Engl. 47. Jahrgang, Nr.20, 2008, S.3759–3761, doi:10.1002/anie.200800282, PMID 18399551.
Le Qm et al.: Avian flu, isolation of drug-resistant H5N1 virus. In: Nature, London 2005, Band 437, Nr. 7062, 20. Oktober, S. 1108, PMID 16228009.
pitt.edu
ccc.chem.pitt.edu
Satoh N, Akiba T, Yokoshima S, Fukuyama T: A practical synthesis of (−)-oseltamivir. In: Angew. Chem. Int. Ed. Engl. 46. Jahrgang, Nr.30, 2007, S.5734–5736, doi:10.1002/anie.200701754, PMID 17594704 (pitt.edu [PDF]).